We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$296M
(-9.9%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$26.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$24.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$19.8M |
| 4 |
Morgan Stanley
MS
|
+$18.5M |
| 5 |
Kraft Heinz
KHC
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$22.3M |
| 2 |
Amgen
AMGN
|
+$21.9M |
| 3 |
Alibaba
BABA
|
+$18.9M |
| 4 |
SLB Ltd
SLB
|
+$18M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.76% |
| 2 | Technology | 13.33% |
| 3 | Consumer Discretionary | 12.45% |
| 4 | Industrials | 11.02% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGR
1001
DELISTED
Aegerion Pharmaceuticals
AEGR
| $344K | 0.01% |
25,366
-113,750
| -82% | -$2.03M |
|
1002
SPS Commerce
SPSC
$2.55B
| $342K | 0.01% |
10,098
-2,366
| -19% | -$82.6K |
|
|
MAGN
1003
Magnera Corp
MAGN
$493M
| $340K | 0.01% |
+1,520
| New | +$377K |
|
|
LPNT
1004
DELISTED
LifePoint Health, Inc.
LPNT
| $339K | 0.01% |
+4,788
| New | +$388K |
|
|
MCHB
1005
Mechanics Bancorp
MCHB
$3.65B
| $338K | 0.01% |
+14,644
| New | +$331K |
|
|
VSI
1006
DELISTED
Vitamin Shoppe Inc.
VSI
| $338K | 0.01% |
+10,365
| New | +$370K |
|
1007
Northrop Grumman
NOC
$76B
| $337K | 0.01% |
+2,035
| New | +$341K |
|
1008
Orthofix Medical
OFIX
$492M
| $337K | 0.01% |
+10,005
| New | +$356K |
|
|
SRDX
1009
DELISTED
Surmodics
SRDX
| $337K | 0.01% |
+15,438
| New | +$362K |
|
|
AMWD
1010
DELISTED
American Woodmark
AMWD
| $336K | 0.01% |
5,193
-4,594
| -47% | -$290K |
|
|
CLLS
1011
Cellectis
CLLS
$288M
| $336K | 0.01% |
12,765
+5,572
| +77% | +$187K |
|
1012
EastGroup Properties
EGP
$11.2B
| $335K | 0.01% |
+6,194
| New | +$349K |
|
1013
Bassett Furniture
BSET
$169M
| $333K | 0.01% |
11,968
-1,398
| -10% | -$44.9K |
|
1014
Chegg
CHGG
$116M
| $333K | 0.01% |
46,268
-141,526
| -75% | -$1.12M |
|
|
SHLM
1015
DELISTED
Schulman (A.) Inc
SHLM
| $332K | 0.01% |
10,229
-1,840
| -15% | -$65K |
|
1016
InterContinental Hotels
IHG
$23.8B
| $331K | 0.01% |
7,257
-15,347
| -68% | -$785K |
|
|
FTD
1017
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $329K | 0.01% |
11,053
-29,801
| -73% | -$879K |
|
|
MOBL
1018
DELISTED
MobileIron, Inc.
MOBL
| $329K | 0.01% |
106,204
+88,325
| +494% | +$406K |
|
1019
Huntsman Corp
HUN
$2.1B
| $327K | 0.01% |
33,799
+3,126
| +10% | +$53.8K |
|
|
SPIL
1020
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $327K | 0.01% |
52,153
+16,582
| +47% | +$103K |
|
|
VASC
1021
DELISTED
Vascular Solutions Inc
VASC
| $327K | 0.01% |
10,097
-7,019
| -41% | -$251K |
|
1022
First Financial Bancorp
FFBC
$3.55B
| $325K | 0.01% |
+17,080
| New | +$317K |
|
|
FARO
1023
DELISTED
Faro Technologies
FARO
| $323K | 0.01% |
+9,233
| New | +$365K |
|
1024
G-III Apparel Group
GIII
$1.54B
| $323K | 0.01% |
+5,241
| New | +$360K |
|
|
CMRX
1025
DELISTED
Chimerix, Inc.
CMRX
| $323K | 0.01% |
+8,480
| New | +$419K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
- A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
- A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
- A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
- A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
- A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
- A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
- A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.
Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.